Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)

Historical Holders from Q4 2019 to Q3 2025

Symbol
CRDL on Nasdaq
Type / Class
Equity / Class A Common Shares
Shares outstanding
98,656,192
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
7,140,522
Holdings value
$7,645,639
% of all portfolios
0%
Number of holders
46
Number of buys
20
Number of sells
-19
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tejara Capital Ltd 5.2% $5,323,528 5,130,122 Tejara Capital Ltd 17 Oct 2025

Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 7,140,522 $7,645,639 +$839,148 $1.07 46
2025 Q2 6,465,422 $8,796,830 -$1,669,184 $1.36 38
2025 Q1 7,719,601 $7,435,013 +$182,305 $0.9698 38
2024 Q4 7,493,301 $9,599,808 +$3,011,551 $1.28 43
2024 Q3 4,972,709 $9,852,940 -$780,395 $1.98 41
2024 Q2 5,391,195 $10,832,854 -$2,207,214 $2.02 41
2024 Q1 6,466,600 $11,532,275 +$17,221 $1.81 32
2023 Q4 6,828,316 $5,921,144 +$428,207 $0.8431 29
2023 Q3 6,315,038 $5,705,102 -$336,357 $0.895 31
2023 Q2 6,680,430 $5,957,333 -$451,394 $0.89 30
2023 Q1 7,243,437 $3,537,761 +$172,240 $0.4873 31
2022 Q4 5,656,495 $2,897,996 +$187,861 $0.51 28
2022 Q3 4,751,290 $4,889,869 -$537,769 $1.03 22
2022 Q2 5,288,416 $6,964,240 -$155,145 $1.32 24
2022 Q1 5,387,006 $8,272,481 -$917,566 $1.54 26
2021 Q4 5,796,080 $10,710,997 +$7,739,960 $1.85 27
2021 Q3 1,605,991 $6,624,465 +$6,624,465 $4.13 19
2021 Q1 0 $0 -$970,000 0
2020 Q4 348,769 $970,000 +$171,498 $2.78 1
2020 Q3 287,106 $876,000 +$133,036 $3.05 1
2020 Q2 243,504 $577,000 +$78,276 $2.37 1
2020 Q1 210,470 $600,000 +$50,715 $2.85 1
2019 Q4 192,680 $681,000 $3.53 1